Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital

Foot

Volumn 22, Issue 1, 2012, Pages 24-30

  Zubair, Mohammad ^a   Malik, Abida ^a   Ahmad, Jamal ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Amputation; Diabetic foot ulcer; India; Risk factors

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; CHLORAMPHENICOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMIPENEM; LINCOSAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROLIDE; METRONIDAZOLE; MONOBACTAM; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIACYLGLYCEROL;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC FOOT; DYSLIPIDEMIA; ENDOCRINOLOGY; FEMALE; FOOT AMPUTATION; FOOT ULCER; HUMAN; HYPERTENSION; INCIDENCE; INDIA; KIDNEY DISEASE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; OSTEOMYELITIS; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL;

AMPUTATION; CARDIOVASCULAR DISEASES; DIABETIC FOOT; FEMALE; FOLLOW-UP STUDIES; HOSPITALS; HUMANS; INCIDENCE; INDIA; KIDNEY DISEASES; LEUKOCYTOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84857457227     PISSN: 09582592     EISSN: 15322963     Source Type: Journal    
DOI: 10.1016/j.foot.2011.09.003     Document Type: Article

References (25)

1. Zubair M., Abida M., Jamal A. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. The Foot 2011, 21(1):6-14.
2. McCabe C.J., Stevenson R.C., Dolan A.M. Evaluation of a diabetic foot screening and protection program. Diabetic Medicine 1998, 15:80-84.
3. Brasil.Ministério da Saúde Diabetes mellitus comoproblema de saúdepública. Brasil. Ministério da Saúde. Manual de Diabetes 1993, Brasília.Ministério da Saúde, pp. 7-10. 2a ed.
4. Vishwanathan V., Kumpatla S. Pattern and causes of amputation in diabetic patients-a multicentric study from India. Journal of the Association of Physicians of India 2011, 59:148-151.
5. Yang W.Y., Lu J.M., Weng J.P., Jia W.P., Ji L.N., Xiao J.Z., et al. Prevalence of diabetes among men and women in China. New England Journal of Medicine 2010, 362:1090-1101.
6. Zubair M., Malik A., Ahmad J., Rizvi M., Farooqui K.J., Rizvi M.W. A study of biofilm production by gram negative organisms isolated from diabetic foot ulcer patients. Biology and Medicine 2011, 3(2):147-157. [special issue].
7. Aleem M.A. Factors that precipitate development of diabetic foot ulcers in rural India. Lancet 2003, 362:1858.
8. Resnick H.E., Carter E.A., Sosenko J.M., Henly S.J., Fabsitz R.R., Ness F.K.et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care 2004, 27:1885-1891.
9. Lee J.S., Lu M., Lee V.S., Russell D., Bahr C., Lee E.T. Lower-extremity amputation: incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes 1993, 42:876-882.
10. Nelson R.G., Gohdes D.M., Everhart J.E., Hartner J.A., Zwemer F.L., Pettitt D.J., et al. Lower-extremity amputations in NIDDM: 12-yr follow-up study in Pima Indians. Diabetes Care 1988, 11:8-16.
11. Oyibo S.O., Jude E.B., Tarawneh I., Nguyen H.C., Armstrong D.G., Harkless L.B., et al. The effect of ulcer size and site, patients age, sex and type and duration of diabetes on the outcome of diabetic foot ulcer. Diabetic Medicine 2001, 18:1343-1348.
12. Boulton A.J., Vileikyte L., RagnarsonTennvall G., Aplevist J. The global burden of diabetic foot disease. Lancet 2005, 366:1719-1724.
13. Yesil S., Akinci B., Yener S., Bayraktar F., Karabay O., Havitcioglu H., et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormone 2009, 8:286-295.
14. Fleischer A.E., Wrobel J.S., Leonars A., Berg S., Evans D.P., Baron R.L., Armstrong D.G. Post treatment leucocytosis predicts an unfavourable clinical response in patients with moderate to severe diabetic foot infections. Journal of Foot and Ankle Surgery 2011, 50(5):541-546.
15. Nordesrgaard B.G., Benn M., Schcohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Journal of the American Medical Association 2007, 298:299-308.
16. Chaturvedi N., Stevens L.K., Fuller J.H., Lee E.T., Lu M. Risk factors, ethnic differences and mortality associated with lower extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes. Diabetologia 2001, 44(Suppl. 2):S65-S71.
17. Gurlek A., Bayraktar M., Savas C., Gedik O. Amputation rate in 147 Turkish patients with diabetic foot: the Hacettepe University Hospital Experience. Experimental and Clinical Endocrinology & Diabetes 1998, 106(5):404-409.
18. Winkley K., Daniel S., Trudie C., Michael E.D., Ismaila K. Risk factors associated with adverse outcomes in a population-basedprospective cohort study of people with their first diabetic foot ulcer. Journal of Diabetes and Its Complications 2007, 21:341-349.
19. Mah T., O'Toole G. Mechanisms of biofilm resistance to antimicrobial agents. Trends in Microbiology 2001, 9:34-39.
20. Leid J. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infection and Immunity 2002, 70:6339-6345.
21. Ramakant P., Verma A.K., Misra R., Prasad K.N., Chand G., Misra A., et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for rethink on which empirical therapy to choose?. Diabetologia 2011, 54:58-64.
22. Lipsky B.A., Pecoraro R.E., Larson S.A., Hanley M.A., Ahroni J.H. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Archives of Internal Medicine 1990, 150:790-797.
23. Scher K., Steele F. The septic foot in patients with diabetes. Surgery 1988, 104:661-666.
24. Lipsky B.A., Berendt A.R. Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes/Metabolism Research and Reviews 2000, 16(Suppl. 1):42-46.
25. Hartemann-Heurtier A., Robert J., Jacqueminet S., Ha Van G., Golmard J.L., Jarlier V., et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabetic Medicine 2004, 21:710-715.